Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032

Overview

The Global Alpha and Beta Emitters Based Radiopharmaceuticals Market is expected to reach a 1,768.17 USD Million by 2032 and is projected to grow at a CAGR of 10.44% from 2025 to 2032.

Revenue, 2024 (USD Million)

801.45

Forecast, 2032 (USD Million)

1,768.17

CAGR, 2024 - 2032

10.44%

Report Coverage

Global

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market 2018-2032 USD Million

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 801.45 USD Million
Projected Market Size (2032): 1,768.17 USD Million
CAGR (2025-2032): 10.44%

Key Findings of Global Alpha and Beta Emitters Based Radiopharmaceuticals Market

The Global Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at 801.45 USD Million in 2024.
The Global Alpha and Beta Emitters Based Radiopharmaceuticals Market is likely to grow at a CAGR of 10.44% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Beta Emitters in Isotope Segment accounted for the largest share of the market with a revenue of 679.19 USD Million
The fastest growing segment Small Molecule Ligands in Vector Type Segment grew Fastest with a CAGR of 11.12% during the forecast period from 2024 to 2032.

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Scope

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Segmentation & Scope

Therapeutic Application

Others
Oncology

Vector Type

Others
Monoclonal Antibodies
Peptides
Small Molecule Ligands

End User

Research Institutes
Radiopharmacies
Hospitals

Sources

Others
Generator-Produced Isotopes
Reactor-Produced Isotopes

Isotope

Alpha Emitters
Beta Emitters

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Data Coverage Insights

Study Period	2024-2032
Base Year	2024
Unit	Revenue in USD Million
Market Value in 2024	801.45 USD Million
Market Value in 2032	1,768.17 USD Million
CAGR (2025-2032)	10.44%
Historic Data	2016-2023
Market Segments Covered	Therapeutic Application,Vector Type,End User,Sources,Isotope

Regional Insights:

Leading Market (2024-2032): Global, leading in terms of revenue 801.45 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 148.50 USD Million in 2024.

Segments and Scope

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Therapeutic Application
- Oncology is the largest segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 615.89 USD Million in the year 2024.
- Oncology is the Fastest growing segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.80 % in forecast period 2025-2032.
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Vector Type
- Small Molecule Ligands is the largest segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 412.79 USD Million in the year 2024.
- Small Molecule Ligands is the Fastest growing segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.12 % in forecast period 2025-2032.
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 454.48 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.66 % in forecast period 2025-2032.
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Sources
- Reactor-Produced Isotopes is the largest segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 495.27 USD Million in the year 2024.
- Reactor-Produced Isotopes is the Fastest growing segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.64 % in forecast period 2025-2032.
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Isotope
- Beta Emitters is the largest segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 679.19 USD Million in the year 2024.
- Beta Emitters is the Fastest growing segment in Global Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.49 % in forecast period 2025-2032.

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Share Analysis

Company Name
Novartis AG
Eckert & Ziegler
ITM Isotope Technologies Munich SE
SHINE Technologies, LLC

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Million

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Profiling

Industry Related Reports

Global Scleroderma Treatment Market

Global Cold Sore Treatment Market

Global Drug-Device Combination Market

Global Down Syndrome Market

Global Small Molecule Sterile Injectable Drugs Market

Global Lymphangioleiomyomatosis (LAM) Market

Global Medicinal Chemistry for Drug Discovery Market

Global Laxative Market

Global Dandruff Treatment Market

Global Dengue Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Global Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The Global Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Therapeutic Application,Vector Type,End User,Sources,Isotope.

What is the current market size of the Global Alpha and Beta Emitters Based Radiopharmaceuticals Market?

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 801.45(Revenue in USD Million) in 2024.

What is the expected growth rate of the Global Alpha and Beta Emitters Based Radiopharmaceuticals Market?

Global Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 10.44% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Global Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The Beta Emitters segment is expected to dominate the Global Alpha and Beta Emitters Based Radiopharmaceuticals Market, holding a largest market share of 679.19 USD Million in 2024